VEGFA and neoplasm: For example, anti-vascular endothelial growth factor (VEGF) agents (e.g., apatinib and bevacizumab) have shown positive effects on tumor vascular normalization and rescued infiltration of T cells into the tumor bed with an increase in chemokines (e.g., CXCL1) [69,70].